Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Medtronic Inc (MDT)

Medtronic Inc (MDT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 146,698,192
  • Shares Outstanding, K 1,341,670
  • Annual Sales, $ 30,557 M
  • Annual Income, $ 4,631 M
  • 60-Month Beta 0.65
  • Price/Sales 4.83
  • Price/Cash Flow 15.00
  • Price/Book 2.90

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 10/31/19
See More
  • Average Estimate 1.28
  • Number of Estimates 13
  • High Estimate 1.29
  • Low Estimate 1.27
  • Prior Year 1.22
  • Growth Rate Est. (year over year) +4.92%

Price Performance

See More
Period Period Low Period High Performance
1-Month
103.02 +6.13%
on 08/19/19
111.24 -1.71%
on 09/12/19
+6.58 (+6.40%)
since 08/16/19
3-Month
96.52 +13.28%
on 06/27/19
111.24 -1.71%
on 09/12/19
+12.02 (+12.35%)
since 06/17/19
52-Week
81.66 +33.90%
on 01/08/19
111.24 -1.71%
on 09/12/19
+13.31 (+13.86%)
since 09/17/18

Most Recent Stories

More News
MiniMed(TM) 670G System European Real-World Data Shows 73% Time in Range, Beyond Recommended Targets

DUBLIN, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions today announced real-world clinical outcomes on European patients...

MDT : 109.34 (+0.27%)
Zacks.com featured highlights include: Lithia Motors, Medtronic, Target, Universal Forest Products and Allegiant Travel

Zacks.com featured highlights include: Lithia Motors, Medtronic, Target, Universal Forest Products and Allegiant Travel

TGT : 107.28 (+0.30%)
ALGT : 151.52 (+0.56%)
MDT : 109.34 (+0.27%)
UFPI : 40.14 (-0.99%)
LAD : 132.40 (+2.26%)
Medtronic Collaborates With Novo Nordisk for Diabetes Care

This collaboration is expected to boost Medtronic's (MDT) diabetes management portfolio.

AMED : 132.38 (+1.11%)
BAX : 87.57 (+0.75%)
MDT : 109.34 (+0.27%)
HAE : 127.05 (+0.88%)
Americas GERD & NERD treatment market: key Vendors, Trends, Analysis, Segmentation, Forecast to 2018-2023

Gerd & Nerd Treatment Market Information, By Drug Class (Antacids (Acid Neutralizers), Proton Pump Inhibitors, H2 Receptor Blocker), Dosage Form (Solid and Liquid), End User (Hospitals & Clinics, Research...

VRX.TO : 30.80 (-3.33%)
STIM : 10.96 (+4.38%)
IRWD : 9.52 (-1.35%)
AZN : 43.13 (+1.46%)
BSX : 42.32 (+0.91%)
MDGS : 1.86 (-4.12%)
CEMP : 2.33 (+1.30%)
MDT : 109.34 (+0.27%)
ESALF : 50.5000 (-2.88%)
GSK : 41.10 (+1.23%)
North America Durable Medical Equipment Market to 2027 with Performance of Key Players - Medtronic, BD, Medline Industries - ResearchAndMarkets.com

The "North America Durable Medical Equipment Market to 2027 - Regional Analysis and Forecasts by Device Type, End User and Geography" report has been added to ResearchAndMarkets.com's offering.

MDT : 109.34 (+0.27%)
Medtronic Introduces Envision(TM) Pro Continuous Glucose Monitoring (CGM) System in Europe

Next-Generation Professional CGM Combines Valuable Data with Optimal User Experience

MDT : 109.34 (+0.27%)
Medtronic Announces Robotic-Assisted Surgery Investor Update

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will host aRobotic-Assisted Surgery (RAS) Investor Update on Tuesday, September 24, 2019, in Hartford, Conn.,...

MDT : 109.34 (+0.27%)
Zacks.com featured highlights include: Medtronic, Symantec, Target, Popular and Baxter International

Zacks.com featured highlights include: Medtronic, Symantec, Target, Popular and Baxter International

BPOP : 53.85 (-0.46%)
TGT : 107.28 (+0.30%)
BAX : 87.57 (+0.75%)
SYMC : 24.43 (+0.70%)
MDT : 109.34 (+0.27%)
National Osteoporosis Foundation Supports New Evidence-Based Care Pathway Designed to Optimize Care for Vertebral Compression Fractures (VCF)

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the National Osteoporosis Foundation (NOF) supports the VCF Care Pathway, a new evidence-based clinical care pathway...

MDT : 109.34 (+0.27%)
Medtronic (MDT) Earns Dow Jones Sustainability Recognition

Medtronic's (MDT) strong ESG practices facilitate inclusion in the North American Dow Jones Sustainability Index.

NTRP : 0.82 (-6.29%)
GWPH : 137.64 (+0.45%)
BAX : 87.57 (+0.75%)
MDT : 109.34 (+0.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More Share

Trade MDT with:

Business Summary

Medtronic Public Limited Company, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. The company is focused on collaborating with stakeholders...

See More

Key Turning Points

2nd Resistance Point 110.51
1st Resistance Point 109.93
Last Price 109.34
1st Support Level 108.86
2nd Support Level 108.37

See More

52-Week High 111.24
Last Price 109.34
Fibonacci 61.8% 99.94
Fibonacci 50% 96.45
Fibonacci 38.2% 92.96
52-Week Low 81.66

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar